MediFind
Condition

Familial Mediterranean Fever

Symptoms, Doctors, Treatments, Research & More

Latest Research

Latest Advance
Study
  • Condition: Polyarticular Juvenile Idiopathic Arthritis
  • Journal: RMD open
  • Treatment Used: Adalimumab with or without Methotrexate
  • Number of Patients: 171
  • Published —
The study researched the outcomes of adalimumab with or without methotrexate for polyarticular juvenile idiopathic arthritis.
Latest Advance
Study
  • Condition: Monogenic Autoinflammatory Diseases and PFAPA Syndrome
  • Journal: Frontiers in immunology
  • Treatment Used: anti-IL-1 agents and other biologic drugs
  • Number of Patients: 0
  • Published —
This review analyzed the treatment of the most frequent monogenic autoinflammatory diseases.
Latest Advance
Study
  • Condition: Pediatric Rheumatic Diseases
  • Journal: The Turkish journal of pediatrics
  • Treatment Used: Canakinumab
  • Number of Patients: 29
  • Published —
In this study, researchers evaluated the outcomes of using canakinumab for the treatment of pediatric rheumatic diseases.
Latest Advance
Study
  • Condition: Familial Mediterranean Fever
  • Journal: The American journal of case reports
  • Treatment Used: Physiological Glucocorticoids
  • Number of Patients: 0
  • Published —
This case report describes a Japanese patient with familial Mediterranean fever and adrenocorticotropic hormone deficiency who was non-compliant with hydrocortisone replacement therapy.
Latest Advance
Study
  • Condition: Familial Mediterranean Fever
  • Journal: The American journal of case reports
  • Treatment Used: Medical Cannabis
  • Number of Patients: 2
  • Published —
This case reported on two patients with familial Mediterranean fever treated with medical cannabis.
Latest Advance
Study
  • Condition: Recipients of Kidney Transplant With Familial Mediterranean Fever (FMF)
  • Journal: Transplantation proceedings
  • Treatment Used: Canakinumab
  • Number of Patients: 4
  • Published —
This case series presented experience with patients with familial Mediterranean fever (FMF) and end-stage renal disease who were colchicine- resistant and on other alternative therapies, which provided poor disease control.
Latest Advance
Study
  • Condition: Familial Mediterranean Fever (FMF) with Amyloidosis
  • Journal: Medical hypotheses
  • Treatment Used: IL-1 Blockers and Colchicine as First Line Therapy
  • Number of Patients: 0
  • Published —
This article discusses the treatment of familial Mediterranean fever (FMF) with amyloidosis with the first line therapy of IL-1 blockers combined with colchicine.
Latest Advance
Study
  • Condition: Children with Familial Mediterranean Fever (FMF)
  • Journal: Rheumatology (Oxford, England)
  • Treatment Used: Cessation of Colchicine
  • Number of Patients: 1786
  • Published —
This study defined the characteristics of children expressing the familial Mediterranean fever (FMF) phenotype under colchicine until it was ceased and to compare the clinical features of patients requiring colchicine again with the patients who did not need colchicine.
Latest Advance
Study
  • Condition: Familial Mediterranean Fever (FMF)
  • Journal: Clinical rheumatology
  • Treatment Used: Interleukin-1 Antagonists
  • Number of Patients: 44
  • Published —
This study investigated quality of life (QoL) changes of patients with chronic Familial Mediterranean fever (FMF) with IL-1 inhibitors.
Latest Advance
Study
  • Condition: Children With Periodic Fever Syndromes
  • Journal: Clinical pharmacology and therapeutics
  • Treatment Used: Canakinumab
  • Number of Patients: 0
  • Published —
The study researched the effects of Canakinumab for children with periodic fever syndromes.